Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
Identifieur interne : 000327 ( PubMed/Curation ); précédent : 000326; suivant : 000328Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
Auteurs : Hicham Fettah ; Youssef Moutaouakkil ; Mohamed Reda Sefrioui ; Badreddine Moukafih ; Yassir Bousliman ; Ahmed Bennana [Maroc] ; Jamal Lamsaouri [Maroc] ; Sanaa Makram ; Yahia CherrahSource :
- The Pan African medical journal [ 1937-8688 ] ; 2018.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Effets secondaires indésirables des médicaments (épidémiologie), Femelle (MeSH), Hospitalisation (MeSH), Humains (MeSH), Hôpitaux d'enseignement (MeSH), Hôpitaux militaires (MeSH), Interactions médicamenteuses (MeSH), Jeune adulte (MeSH), Maladies cardiovasculaires (traitement médicamenteux), Maroc (épidémiologie), Mâle (MeSH), Prévalence (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Études prospectives (MeSH).
- MESH :
- traitement médicamenteux : Maladies cardiovasculaires.
- épidémiologie : Effets secondaires indésirables des médicaments, Maroc.
- Adulte, Adulte d'âge moyen, Femelle, Hospitalisation, Humains, Hôpitaux d'enseignement, Hôpitaux militaires, Interactions médicamenteuses, Jeune adulte, Mâle, Prévalence, Sujet âgé, Sujet âgé de 80 ans ou plus, Études prospectives.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Cardiovascular Diseases (drug therapy), Drug Interactions (MeSH), Drug-Related Side Effects and Adverse Reactions (epidemiology), Female (MeSH), Hospitalization (MeSH), Hospitals, Military (MeSH), Hospitals, Teaching (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Morocco (epidemiology), Prevalence (MeSH), Prospective Studies (MeSH), Young Adult (MeSH).
- MESH :
- drug therapy : Cardiovascular Diseases.
- epidemiology : Drug-Related Side Effects and Adverse Reactions, Morocco.
- Adult, Aged, Aged, 80 and over, Drug Interactions, Female, Hospitalization, Hospitals, Military, Hospitals, Teaching, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Young Adult.
Abstract
Introduction
Drug-drug interactions (DDIs) are defined as two or more drugs interacting in such a manner that the effectiveness or toxicity of one or more drugs is altered. Patients with cardiovascular disorders are at higher risk for DDIs because of the types and number of drugs they receive. The aim of the present study was to assess the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco.
Methods
A prospective observational study from June 2016 to September 2016 was carried out in the cardiology department of a hospital in Morocco. Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study. The medications of the patients were analysed for possible interactions. All the prescriptions of the study population were screened for drug-drug interactions using a computerized DDI database system (Theriaque
Results
During the study period, 138 patients were included; 360 interactions were detected among 94 patients, with an average number of drugs taken of 5.2. The prevalence of DDIs was estimated at 68.11%, the most common of which concerned Kardegic/Plavix (12.22%), Kardegic/Heparin (8.33%), and Lasilix/Spironolactone (5.83%). Among the 726 prescribed drugs, (372 [51.24%]) were drugs of the cardiovascular system, followed by blood and hematopoietic organ drugs (288 [39.67%]) according to the Anatomical Therapeutic Chemical Classification codes. These interactions were categorized on the basis of level of severity: interactions with major severity accounted for 11.11% (40) of the total DDIs while those with moderate and minor severity accounted for 37.22% (134) and 51.66% (186), respectively.
Conclusion
This study reports the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco. This study shows that DDIs are frequent among hospitalized cardiac patients and highlights the need to screen prescriptions of cardiovascular patients for possible DDIs, as this helps in their detection and prevention.Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net)Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net).
DOI: 10.11604/pamj.2018.29.225.14169
PubMed: 30100979
PubMed Central: PMC6080962
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000328
Links to Exploration step
pubmed:30100979Curation
No country items
Hicham Fettah<affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.</title><author><name sortKey="Fettah, Hicham" sort="Fettah, Hicham" uniqKey="Fettah H" first="Hicham" last="Fettah">Hicham Fettah</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Moutaouakkil, Youssef" sort="Moutaouakkil, Youssef" uniqKey="Moutaouakkil Y" first="Youssef" last="Moutaouakkil">Youssef Moutaouakkil</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Sefrioui, Mohamed Reda" sort="Sefrioui, Mohamed Reda" uniqKey="Sefrioui M" first="Mohamed Reda" last="Sefrioui">Mohamed Reda Sefrioui</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Moukafih, Badreddine" sort="Moukafih, Badreddine" uniqKey="Moukafih B" first="Badreddine" last="Moukafih">Badreddine Moukafih</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Bousliman, Yassir" sort="Bousliman, Yassir" uniqKey="Bousliman Y" first="Yassir" last="Bousliman">Yassir Bousliman</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Bennana, Ahmed" sort="Bennana, Ahmed" uniqKey="Bennana A" first="Ahmed" last="Bennana">Ahmed Bennana</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat</wicri:regionArea></affiliation></author><author><name sortKey="Lamsaouri, Jamal" sort="Lamsaouri, Jamal" uniqKey="Lamsaouri J" first="Jamal" last="Lamsaouri">Jamal Lamsaouri</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat</wicri:regionArea></affiliation></author><author><name sortKey="Makram, Sanaa" sort="Makram, Sanaa" uniqKey="Makram S" first="Sanaa" last="Makram">Sanaa Makram</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Cherrah, Yahia" sort="Cherrah, Yahia" uniqKey="Cherrah Y" first="Yahia" last="Cherrah">Yahia Cherrah</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30100979</idno><idno type="pmid">30100979</idno><idno type="doi">10.11604/pamj.2018.29.225.14169</idno><idno type="pmc">PMC6080962</idno><idno type="wicri:Area/PubMed/Corpus">000328</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000328</idno><idno type="wicri:Area/PubMed/Curation">000327</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000327</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.</title><author><name sortKey="Fettah, Hicham" sort="Fettah, Hicham" uniqKey="Fettah H" first="Hicham" last="Fettah">Hicham Fettah</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Moutaouakkil, Youssef" sort="Moutaouakkil, Youssef" uniqKey="Moutaouakkil Y" first="Youssef" last="Moutaouakkil">Youssef Moutaouakkil</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Sefrioui, Mohamed Reda" sort="Sefrioui, Mohamed Reda" uniqKey="Sefrioui M" first="Mohamed Reda" last="Sefrioui">Mohamed Reda Sefrioui</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Moukafih, Badreddine" sort="Moukafih, Badreddine" uniqKey="Moukafih B" first="Badreddine" last="Moukafih">Badreddine Moukafih</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Bousliman, Yassir" sort="Bousliman, Yassir" uniqKey="Bousliman Y" first="Yassir" last="Bousliman">Yassir Bousliman</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Bennana, Ahmed" sort="Bennana, Ahmed" uniqKey="Bennana A" first="Ahmed" last="Bennana">Ahmed Bennana</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat</wicri:regionArea></affiliation></author><author><name sortKey="Lamsaouri, Jamal" sort="Lamsaouri, Jamal" uniqKey="Lamsaouri J" first="Jamal" last="Lamsaouri">Jamal Lamsaouri</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat</wicri:regionArea></affiliation></author><author><name sortKey="Makram, Sanaa" sort="Makram, Sanaa" uniqKey="Makram S" first="Sanaa" last="Makram">Sanaa Makram</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author><author><name sortKey="Cherrah, Yahia" sort="Cherrah, Yahia" uniqKey="Cherrah Y" first="Yahia" last="Cherrah">Yahia Cherrah</name><affiliation><nlm:affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</nlm:affiliation><wicri:noCountry code="subField">Rabat-Morocco</wicri:noCountry></affiliation></author></analytic><series><title level="j">The Pan African medical journal</title><idno type="eISSN">1937-8688</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Cardiovascular Diseases (drug therapy)</term><term>Drug Interactions (MeSH)</term><term>Drug-Related Side Effects and Adverse Reactions (epidemiology)</term><term>Female (MeSH)</term><term>Hospitalization (MeSH)</term><term>Hospitals, Military (MeSH)</term><term>Hospitals, Teaching (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Morocco (epidemiology)</term><term>Prevalence (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Effets secondaires indésirables des médicaments (épidémiologie)</term><term>Femelle (MeSH)</term><term>Hospitalisation (MeSH)</term><term>Humains (MeSH)</term><term>Hôpitaux d'enseignement (MeSH)</term><term>Hôpitaux militaires (MeSH)</term><term>Interactions médicamenteuses (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Maladies cardiovasculaires (traitement médicamenteux)</term><term>Maroc (épidémiologie)</term><term>Mâle (MeSH)</term><term>Prévalence (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cardiovascular Diseases</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Drug-Related Side Effects and Adverse Reactions</term><term>Morocco</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies cardiovasculaires</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Effets secondaires indésirables des médicaments</term><term>Maroc</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Drug Interactions</term><term>Female</term><term>Hospitalization</term><term>Hospitals, Military</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Prospective Studies</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Hôpitaux d'enseignement</term><term>Hôpitaux militaires</term><term>Interactions médicamenteuses</term><term>Jeune adulte</term><term>Mâle</term><term>Prévalence</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Introduction</b></p><p>Drug-drug interactions (DDIs) are defined as two or more drugs interacting in such a manner that the effectiveness or toxicity of one or more drugs is altered. Patients with cardiovascular disorders are at higher risk for DDIs because of the types and number of drugs they receive. The aim of the present study was to assess the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco.</p></div><div type="abstract" xml:lang="en"><p><b>Methods</b></p><p>A prospective observational study from June 2016 to September 2016 was carried out in the cardiology department of a hospital in Morocco. Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study. The medications of the patients were analysed for possible interactions. All the prescriptions of the study population were screened for drug-drug interactions using a computerized DDI database system (Theriaque</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>During the study period, 138 patients were included; 360 interactions were detected among 94 patients, with an average number of drugs taken of 5.2. The prevalence of DDIs was estimated at 68.11%, the most common of which concerned Kardegic/Plavix (12.22%), Kardegic/Heparin (8.33%), and Lasilix/Spironolactone (5.83%). Among the 726 prescribed drugs, (372 [51.24%]) were drugs of the cardiovascular system, followed by blood and hematopoietic organ drugs (288 [39.67%]) according to the Anatomical Therapeutic Chemical Classification codes. These interactions were categorized on the basis of level of severity: interactions with major severity accounted for 11.11% (40) of the total DDIs while those with moderate and minor severity accounted for 37.22% (134) and 51.66% (186), respectively.</p></div><div type="abstract" xml:lang="en"><p><b>Conclusion</b></p><p>This study reports the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco. This study shows that DDIs are frequent among hospitalized cardiac patients and highlights the need to screen prescriptions of cardiovascular patients for possible DDIs, as this helps in their detection and prevention.Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net)Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net).</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30100979</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.</ArticleTitle><Pagination><MedlinePgn>225</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2018.29.225.14169</ELocationID><Abstract><AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Drug-drug interactions (DDIs) are defined as two or more drugs interacting in such a manner that the effectiveness or toxicity of one or more drugs is altered. Patients with cardiovascular disorders are at higher risk for DDIs because of the types and number of drugs they receive. The aim of the present study was to assess the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">A prospective observational study from June 2016 to September 2016 was carried out in the cardiology department of a hospital in Morocco. Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study. The medications of the patients were analysed for possible interactions. All the prescriptions of the study population were screened for drug-drug interactions using a computerized DDI database system (Theriaque<sup>®</sup>).</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">During the study period, 138 patients were included; 360 interactions were detected among 94 patients, with an average number of drugs taken of 5.2. The prevalence of DDIs was estimated at 68.11%, the most common of which concerned Kardegic/Plavix (12.22%), Kardegic/Heparin (8.33%), and Lasilix/Spironolactone (5.83%). Among the 726 prescribed drugs, (372 [51.24%]) were drugs of the cardiovascular system, followed by blood and hematopoietic organ drugs (288 [39.67%]) according to the Anatomical Therapeutic Chemical Classification codes. These interactions were categorized on the basis of level of severity: interactions with major severity accounted for 11.11% (40) of the total DDIs while those with moderate and minor severity accounted for 37.22% (134) and 51.66% (186), respectively.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">This study reports the prevalence of DDIs in patients admitted to the cardiology department of a hospital in Morocco. This study shows that DDIs are frequent among hospitalized cardiac patients and highlights the need to screen prescriptions of cardiovascular patients for possible DDIs, as this helps in their detection and prevention.Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net)Pan African Medical Journal - ISSN: 1937- 8688 (www.panafrican-med-journal.com)Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fettah</LastName><ForeName>Hicham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutaouakkil</LastName><ForeName>Youssef</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sefrioui</LastName><ForeName>Mohamed Reda</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moukafih</LastName><ForeName>Badreddine</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bousliman</LastName><ForeName>Yassir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennana</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamsaouri</LastName><ForeName>Jamal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makram</LastName><ForeName>Sanaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherrah</LastName><ForeName>Yahia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, Toxicology, Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat-Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="Y">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006772" MajorTopicYN="N">Hospitals, Military</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009018" MajorTopicYN="N">Morocco</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiology</Keyword><Keyword MajorTopicYN="N">drug–drug interactions</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">theriaque</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30100979</ArticleId><ArticleId IdType="doi">10.11604/pamj.2018.29.225.14169</ArticleId><ArticleId IdType="pii">PAMJ-29-225</ArticleId><ArticleId IdType="pmc">PMC6080962</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2004 Jun 2;291(21):2616-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15173153</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Interne. 2010 Feb;31(2):170-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19740579</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Pharmacol. 2014 Mar-Apr;46(2):152-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24741184</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2007 Sep 19;7:147</Citation><ArticleIdList><ArticleId IdType="pubmed">17880689</ArticleId></ArticleIdList></Reference><Reference><Citation>J Fr Ophtalmol. 2009 Jan;32(1):79-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19515320</ArticleId></ArticleIdList></Reference><Reference><Citation>Res Social Adm Pharm. 2007 Dec;3(4):426-37</Citation><ArticleIdList><ArticleId IdType="pubmed">18082877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Otolaryngol Chir Cervicofac. 2004 Feb;121(1):51-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15041835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Liege. 2006 May-Jun;61(5-6):471-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16910278</ArticleId></ArticleIdList></Reference><Reference><Citation>Australas Med J. 2011;4(1):9-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23393498</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Mar 18;320(7237):750-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10720357</ArticleId></ArticleIdList></Reference><Reference><Citation>Farm Hosp. 2008 Sep-Oct;32(5):293-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19150046</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2010 Oct 1;33(10):879-88</Citation><ArticleIdList><ArticleId IdType="pubmed">20812772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2002 Nov;36(11):1675-81</Citation><ArticleIdList><ArticleId IdType="pubmed">12398558</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Intern Med. 2008 Oct;19(6):413-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18848174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Chemother Pharmacol. 2005 Sep;56(3):286-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15731916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000327 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000327 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= MaghrebDataLibMedV2
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:30100979
|texte= Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:30100979" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MaghrebDataLibMedV2
| This area was generated with Dilib version V0.6.38. |  |